The Senate’s latest price setting proposal will undermine: American medical innovation

Posted on August 4, 2022 by Design in Design Innovation | 0 Comments

The drug pricing proposal imposes government price setting in a way that fails to fully accommodate the time needed for generics and biosimilars to come to market.